Patents by Inventor Tim N. Oulmassov

Tim N. Oulmassov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8598412
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: December 3, 2013
    Assignee: Monsanto Technology LLC
    Inventors: Qi Wang, Tanya Fagaly, Ronald Bassuner, Jihong Liang, Tim N. Oulmassov, John Dabrowski
  • Patent number: 8581044
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression during a defined period of embryogenesis. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Grant
    Filed: April 4, 2012
    Date of Patent: November 12, 2013
    Assignee: Monsanto Technology LLC
    Inventors: Qi Wang, Lisa M. Weaver, Tim N. Oulmassov, Jeffrey Ahrens, Patrice Dubois, Jeffery Q. Shen
  • Publication number: 20120317679
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression during a defined period of embryogenesis. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Application
    Filed: April 4, 2012
    Publication date: December 13, 2012
    Inventors: Qi Wang, Lisa M. Weaver, Tim N. Oulmassov, Jeffrey Ahrens, Patrice Dubois, Jeffery Q. Shen
  • Patent number: 8193413
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression during a defined period of embryogenesis. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: June 5, 2012
    Assignee: Monsanto Technology LLC
    Inventors: Qi Wang, Lisa M. Weaver, Tim N. Oulmassov, Jeffrey Ahrens, Patrice Dubois, Jeffrey Q. Shen
  • Patent number: 8158851
    Abstract: The present invention provides a method for altering the tryptophan content of a plant by introducing and expressing an isolated DNA segment encoding an anthranilate synthase in the cells of the plant. Transgenic plants transformed with an isolated DNA segment encoding an anthranilate synthase, as well as human or animal food, seeds and progeny derived from these plants, are also provided.
    Type: Grant
    Filed: January 11, 2010
    Date of Patent: April 17, 2012
    Assignee: Monsanto Technology LLC
    Inventors: Lisa M. Weaver, Tim N. Oulmassov, Gabriela Vaduva, Jihong Liang, Marguerite J. Varagona, Tyamagondlu V. Venkatesh, Sivalinganna Manjunath
  • Publication number: 20120090049
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Application
    Filed: October 1, 2010
    Publication date: April 12, 2012
    Inventors: Qi Wang, Tanya Fagaly, Ronald Bassuner, Jihong Liang, Tim N. Oulmassov, John Dabrowski
  • Publication number: 20110195175
    Abstract: The present invention provides a method for altering the tryptophan content of a plant by introducing and expressing an isolated DNA segment encoding an anthranilate synthase in the cells of the plant. Transgenic plants transformed with an isolated DNA segment encoding an anthranilate synthase, as well as human or animal food, seeds and progeny derived from these plants, are also provided.
    Type: Application
    Filed: January 11, 2010
    Publication date: August 11, 2011
    Inventors: Lisa M. Weaver, Tim N. Oulmassov, Gabriela Vaduva, Jihong Liang, Marguerite J. Varagona, Tyamagondlu V. Venkatesh, Sivalinganna Manjunath
  • Patent number: 7807873
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Grant
    Filed: February 1, 2008
    Date of Patent: October 5, 2010
    Assignee: Monsanto Technology LLC
    Inventors: Qi Wang, Tanya Fagaly, Ronald Bassuner, Jihong Liang, Tim N. Oulmassov, John Dabrowski
  • Publication number: 20100077504
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression during a defined period of embryogenesis. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Application
    Filed: October 2, 2009
    Publication date: March 25, 2010
    Inventors: Qi Wang, Lisa M. Weaver, Tim N. Oulmassov, Jeffrey Ahrens, Patrice Dubois, Jeffrey Q. Shen
  • Patent number: 7615680
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression during a defined period of embryogenesis. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: November 10, 2009
    Assignee: Monsanto Technology LLC
    Inventors: Qi Wang, Lisa M. Weaver, Tim N. Oulmassov, Jeffrey Ahrens, Patrice Dubois, Jeffery Q. Shen
  • Publication number: 20080241341
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Application
    Filed: February 1, 2008
    Publication date: October 2, 2008
    Inventors: Qi Wang, Tanya Fagaly, Ronald Bassuner, Jihong Liang, Tim N. Oulmassov, John Dabrowski
  • Patent number: 7365241
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Grant
    Filed: May 18, 2006
    Date of Patent: April 29, 2008
    Assignee: Monsanto Technology LLC
    Inventors: Qi Wang, Tanya Fagaly, Ronald Bassuner, Jihong Liang, Tim N. Oulmassov, John Dabrowski
  • Patent number: 7202085
    Abstract: DNA constructs and other compositions and methods for controlling gene expression in eukaryotic cells and organisms are derived from bacterial quorum sensing systems. One or more cis elements from the luxI promoter (“lux box”) or a functionally similar sequence are incorporated in a eukaryotic promoter. A receptor protein from the LuxR family of transcriptional regulators, upon binding an acylated homoserine lactone (AHL) compound, interacts with the lux box, modulating the activity of the promoter.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: April 10, 2007
    Assignee: Calgene LLC
    Inventors: Tim N. Oulmassov, Kevin E. McBride, Paula C. Miller, John C. Anderson, Lyle D. Crossland, Thomas H. Adams, Barbara A. Qurollo, Victoria Gavrias
  • Patent number: 7179959
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression during a defined period of embryogenesis. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Grant
    Filed: May 5, 2003
    Date of Patent: February 20, 2007
    Assignee: Renessen LLC
    Inventors: Qi Wang, Lisa M. Weaver, Tim N. Oulmassov, Jeffrey Ahrens, Patrice Dubois, Jeffery Q. Shen
  • Patent number: 7078588
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Grant
    Filed: May 5, 2003
    Date of Patent: July 18, 2006
    Assignee: Renessen LLC
    Inventors: Qi Wang, Tanya Fagaly, Ronald Bassuner, Jihong Liang, Tim N. Oulmassov, John Dabrowski
  • Patent number: 6943243
    Abstract: DNA constructs and other compositions and methods for controlling gene expression in eukaryotic cells and organisms are derived from bacterial quorum sensing systems. One or more cis elements from the luxI promoter (“lux box”) or a functionally similar sequence are incorporated in a eukaryotic promoter. A receptor protein from the LuxR family of transcriptional regulators, upon binding an acylated homoserine lactone (AHL) compound, interacts with the lux box, modulating the activity of the promoter.
    Type: Grant
    Filed: February 6, 2003
    Date of Patent: September 13, 2005
    Assignee: Calgene LLC
    Inventors: Tim N. Oulmassov, Kevin E. McBride, Paula C. Miller, John C. Anderson, Lyle D. Crossland, Thomas H. Adams, Barbara A. Qurollo, Victoria Gavrias
  • Publication number: 20040016024
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression during a defined period of embryogenesis. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Application
    Filed: May 5, 2003
    Publication date: January 22, 2004
    Inventors: Qi Wang, Lisa M. Weaver, Tim N. Oulmassov, Jeffrey Ahrens, Patrice Dubois, Jeffery Q. Shen
  • Publication number: 20030229918
    Abstract: The present invention relates to the field of plant genetic engineering. More specifically, the present invention relates to seed specific gene expression. The present invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
    Type: Application
    Filed: May 5, 2003
    Publication date: December 11, 2003
    Inventors: Qi Wang, Tanya Fagaly, Ronald Bassuner, Jihong Liang, Tim N. Oulmassov, John Dabrowski
  • Publication number: 20030224483
    Abstract: DNA constructs and other compositions and methods for controlling gene expression in eukaryotic cells and organisms are derived from bacterial quorum sensing systems. One or more cis elements from the luxI promoter (“lux box”) or a functionally similar sequence are incorporated in a eukaryotic promoter. A receptor protein from the LuxR family of transcriptional regulators, upon binding an acylated homoserine lactone (AHL) compound, interacts with the lux box, modulating the activity of the promoter.
    Type: Application
    Filed: February 6, 2003
    Publication date: December 4, 2003
    Inventors: Tim N. Oulmassov, Kevin E. McBride, Paula C. Miller, John C. Anderson, Lyle D. Crossland, Thomas H. Adams, Barbara A. Qurollo, Victoria Gavrias
  • Patent number: H2213
    Abstract: The present invention generally relates to the field of plant genetics and protein biochemistry. More specifically, the present invention relates to modified proteins having an increased number of essential amino acids. The present invention provides proteins modified to have an increased number of essential amino acids, nucleic acid sequences encoding the enhanced proteins, and methods of designing, producing, and using the same. The present invention also includes compositions, transformed host cells, transgenic plants, and seeds containing the enhanced proteins, and methods for preparing and using the same.
    Type: Grant
    Filed: April 9, 2003
    Date of Patent: April 1, 2008
    Assignee: Monsanto Technology LLC
    Inventors: Tim N. Oulmassov, William D. Rapp, Kairong Tian, Jason A. Wicker, William J. Welsh, Xia Wang, Robert K. DeLisle, Tyamagondlu V. Venkatesh, Jihong Liang